logo

Clovis Oncology, Inc. (CLVS)



Trade CLVS now with
  Date
  Headline
2/27/2018 8:59:05 AM RBC Capital Markets Is Raising Clovis Oncology, Inc. (CLVS) FY18 Estimate To -5.34 From -5.65
2/27/2018 8:58:51 AM RBC Capital Markets Is Increasing Clovis Oncology, Inc. (CLVS) Q1 18 Estimate To -1.39 From -1.46
2/27/2018 7:12:06 AM Sierra Oncology FY Net Loss $42.0 Mln Vs Net Loss Of $47.9 Mln Last Year
2/21/2018 5:13:39 PM Clovis Oncology Receives Positive Trend Vote From CHMP For Rucaparib Ovarian Cancer Treatment Indication
11/2/2017 12:04:41 PM RBC Capital Markets Is Cutting Clovis Oncology, Inc. (CLVS) 4Q17 Rev. Estimate To 20.9 M From 26.1 M
11/2/2017 12:04:19 PM RBC Capital Markets Is Raising Clovis Oncology, Inc. (CLVS) 2019 Estimate To -1.34 From -1.59
11/2/2017 12:03:58 PM RBC Capital Markets Is Increasing Clovis Oncology, Inc. (CLVS) 2018 Estimate To -3.84 From -4.19
11/2/2017 12:03:35 PM RBC Capital Markets Is Raising Clovis Oncology, Inc. (CLVS) 2017 Estimate To -7.65 From -7.79
11/2/2017 12:03:20 PM RBC Capital Markets Is Lowering Clovis Oncology, Inc. (CLVS) 2017 Rev. Estimate To 59.4 M From 68.6 M